Index of reports
> Cases with Pyrexia (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Oncaspar (Pegaspargase) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Oncaspar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 121.9 kg (268.2 pounds)
Reactions: Pruritus, Unresponsive To Stimuli, Device Related Infection, Pyrexia, Candidiasis, Abscess Limb, Ventricular Extrasystoles, Metabolic Acidosis, Dyspnoea, Hypotension, Pancytopenia, Tremor, Convulsion, Respiratory Failure, Fungal Infection, Ventricular Tachycardia, Sepsis, Respiratory Arrest, Pulse Absent, Sinus Tachycardia, Hypertension, Feeling Abnormal, Cardiac Arrest, Escherichia Infection, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epinephrine
Dosage: 4 df, unk
Indication: Cardiac Arrest
Start date: 2012-07-14
End date: 2012-07-14
Cyclophosphamide
Dosage: daily for 5 days
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Oncaspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Epinephrine
Dosage: unk
Start date: 2012-07-14
End date: 2012-07-14
Clolar
Dosage: 74.4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Vincristine Sulfate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Other drugs received by patient: Colace; Bactrim; Stomatitis Mouthwash; Prilosec; Lortab; Cymbalta; Ondansetron; Ambien
Possible Oncaspar side effects in 17 year old female
Reported by a physician from United States on 2012-06-08
Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)
Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Oncaspar
Indication: T-Cell Type Acute Leukaemia
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-04-13
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Dalteparin Sodium
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole
Possible Oncaspar side effects in 10 year old male
Reported by a physician from United States on 2012-05-24
Patient: 10 year old male, weighing 22.3 kg (49.1 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 27 mg, qd on day 1 and 5
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Methylprednisolone Acetate
Dosage: 9.7 mg, q8h on day 4 to day 32
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-03
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
Afinitor
Dosage: 2 mg, qd on day 1 to day 32
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Oncaspar
Dosage: 2275 iu, qd on days 4 to 32
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Vincristine
Dosage: 1.4 mg, qd on day 4, 11, 18 and 25
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
Other drugs received by patient: Leucovorin Calcium; Ondansetron; Senna-Mint WAF; Colace; Sulfamethoxypyrazine / Trimethoprim; Ondansetron; Concerta; Calcium Carbonate; Clonidine
Possible Oncaspar side effects in 19 year old female
Reported by a physician from United States on 2012-04-24
Patient: 19 year old female, weighing 160.0 kg (352.0 pounds)
Reactions: Axillary Vein Thrombosis, Pyrexia, High Density Lipoprotein Decreased, Very LOW Density Lipoprotein Increased, Vena Cava Thrombosis, Thrombophlebitis, Blood Cholesterol Increased, Hypertriglyceridaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Oncaspar
Dosage: 4500 iu;x1; 2125 iu;x1;
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-01
End date: 2011-12-01
Oncaspar
Dosage: 4500 iu;x1; 2125 iu;x1;
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-17
End date: 2012-01-17
Oncaspar
Dosage: 4500 iu;x1; 2125 iu;x1;
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-14
End date: 2012-02-14
Oncaspar
Possible Oncaspar side effects in 8 year old female
Reported by a pharmacist from United States on 2012-04-02
Patient: 8 year old female, weighing 26.0 kg (57.2 pounds)
Reactions: Hypersensitivity, Vomiting, Nausea, Chills, Pyrexia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Oncaspar
Possible Oncaspar side effects in 29 year old female
Reported by a individual with unspecified qualification from United Kingdom on 2011-10-20
Patient: 29 year old female
Reactions: Mucosal Inflammation, Hyperbilirubinaemia, Oral Pain, Pyrexia
Drug(s) suspected as cause:
Oncaspar
Dosage: (1725 iu, d4+18) intravenous
Start date: 2011-03-21
End date: 2011-04-04
Palifermin (Palifermin)
Dosage: (4.3 mg, per protocol) intravenous
Indication: Stomatitis
Start date: 2011-07-17
End date: 2011-07-30
Palifermin (Palifermin)
Dosage: (4.3 mg, per protocol) intravenous
Indication: Prophylaxis
Start date: 2011-07-17
End date: 2011-07-30
Other drugs received by patient: Itraconazole; Allopurinol; Norethindrone; Difflan (Benzydamine Hydrochloride); Tazocin (Tazocin); Acyclovir; Enoxaparin Sodium; Acyclovir; Benzocaine + Codeine Mouthwash (Benzocaine, Codein); Cyclicine (Cyclicine); Acetaminophen; Codeine Sulfate; Piperacillin and Tazobactam; Chlorhexidine Gluconate; Cyclosporine; Nystatin; Itraconazole; Morphine Sulphate (Morphine Sulphate); Teicoplanin (Teicoplanin); Ondansetron
|